Seattle, WA, United States of America

Jeremy Bjelajac

This inventor holds 1 USPTO granted patent. Top assignee: Seattle Children's Hospital Dba Seattle Children's Research Institute. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeremy Bjelajac. Retrieved from https://idiyas.com/inventor/jeremy-bjelajac

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jeremy Bjelajac

Introduction

Jeremy Bjelajac is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly through his innovative work at Seattle Children's Hospital, also known as Seattle Children's Research Institute. His expertise and dedication to research have led to the development of valuable patents that advance medical science.

Latest Patents

One of Jeremy Bjelajac's notable patents is titled "Self-Inactivating Transposase Plasmids and Uses Thereof." This patent represents a significant advancement in genetic engineering, providing new methods for manipulating genetic material in various applications. His work in this area showcases his commitment to improving healthcare through innovative solutions.

Career Highlights

Throughout his career, Jeremy has focused on research that bridges the gap between science and practical applications in medicine. His role at Seattle Children's Hospital has allowed him to collaborate with leading experts in the field, contributing to groundbreaking research that benefits children and families.

Collaborations

Jeremy Bjelajac has worked closely with his coworker, Joshua Gustafson, to further enhance their research initiatives. Their collaboration exemplifies the importance of teamwork in achieving significant advancements in medical research.

Conclusion

In summary, Jeremy Bjelajac is a dedicated inventor whose work at Seattle Children's Hospital has led to important innovations in biotechnology. His patent on self-inactivating transposase plasmids highlights his contributions to the field and underscores the impact of his research on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…